GENEVA – Doctors Without Borders/Médecins Sans Frontières (MSF) has launched a global campaign calling on pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day for people everywhere who need it, in order to allow scale-up of drug-resistant tuberculosis (DR-TB) treatment and reduce deaths. … Read more
For decades, the global pharmaceutical industry has spread a deceptive narrative justifying the ever-increasing, sky-high prices of drugs, vaccines and diagnostics as something necessary and inevitable. MSF’s Access Campaign has repeatedly challenged this deadly narrative, calling for affordable access to lifesaving medicines, prioritisation of people’s health over profits, and transparency around the research and development (R&D) process. … Read more
Ahead of the Prime Minister Narendra Modi’s visit to the US to discuss a ‘trade-package’ with the US President Donald Trump, Médecins Sans Frontières/ Doctors Without Borders (MSF) urges the Indian government to not make any commitments regarding intellectual property, as it will impact millions of people who rely on affordable generic medicines produced in … Read more
Millions of children around the world remain vulnerable to pneumonia – the leading cause of childhood death – because of exploitative pricing by Pfizer and GSK Nearly one-third of the world’s countries have been unable to introduce the vaccine, largely due to its high price More children could be protected if Gavi reserved its special … Read more
Inaction by US pharmaceutical corporation Gilead to follow through on its so-called ‘access initiative’ leaves people unable to access a vital drug to treat a deadly infection. Delhi/Geneva – Pharmaceutical corporation Gilead Sciences has failed to deliver on promises to make an important drug available to people suffering from a life-threatening HIV-related infection, the medical humanitarian … Read more
On the eve of World Intellectual Property Day, the United States Trade Representative released its annual “Special 301 Report.” Developing countries like India and Malaysia once again face unfair pressure from the US government over the measures these countries have taken to try to protect access to medicines. The Special 301 report is an annual … Read more
MSF protests at Johnson & Johnson’s annual shareholders’ meeting to demand a say in how lifesaving tuberculosis drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable. New Brunswick, New Jersey – At the Johnson & Johnson (J&J) annual shareholders meeting today, the international medical humanitarian … Read more
Mumbai/Cape Town – Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita Venkatesan from Mumbai, India and Phumeza Tisile from Khayelitsha, South Africa, who filed the patent … Read more
Mumbai/Cape Town – Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita Venkatesan from Mumbai, India and Phumeza Tisile from Khayelitsha, South Africa, who filed the … Read more
Geneva —The international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) today welcomed new World Health Organization (WHO) treatment guidelines that recommend drug-resistant tuberculosis (DR-TB) be treated with oral drugs only, including newer, more potent drugs with fewer side effects, such as bedaquiline. Two injectable drugs known to cause deafness and other severe side effects … Read more